Direct oral anticoagulants in cancer-associated venous thromboembolism: It is high time for a change of therapeutic paradigm

Cardiol J. 2020;27(4):347-349. doi: 10.5603/CJ.a2020.0067. Epub 2020 May 18.

Authors

Justyna Domienik-Karłowicz¹, Miłosz Jaguszewski², Marcin Kurzyna³

Affiliations

¹ Department of Internal Medicine and Cardiology, Medical University of Warsaw,. jdomienik@tlen.pl.
² First Department of Cardiology, Medical University of Gdansk, Gdańsk, Poland.
³ Department of Pulmonary Circulation, Thromboembolic Diseases and Cardiology, Centre of Postgraduate Medical Education, European Health Centre Otwock.

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants
Humans
Neoplasms*
Pyrazoles
Pyridones
Venous Thromboembolism*

Substances

Anticoagulants
Pyrazoles
Pyridones
apixaban